Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: Validation across time and place and recommendation for benchmarking

BJU International

Volumn 109, Issue 11, 2012, Pages 1666-1673

  Mariappan, Paramananthan ^a   Finney, Steven M ^a   Head, Elizabeth ^a   Somani, Bhaskar K ^b   Zachou, Alexandra ^a   Smith, Gordon ^a   Mishriki, Said F ^b   N'Dow, James ^b   Grigor, Kenneth M ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

bladder cancer; detrusor muscle; quality control; recurrence; transurethral resection of bladder tumour

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER SURGERY; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; CYSTOSCOPY; DETRUSOR MUSCLE; FEMALE; FOLLOW UP; HUMAN; JOB EXPERIENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; SURGEON; TUMOR VOLUME; UNITED KINGDOM; WHITE LIGHT TRANSURETHRAL RESECTION OF BLADDER TUMOR;

AGED; BENCHMARKING; CLINICAL COMPETENCE; COHORT STUDIES; CYSTECTOMY; CYSTOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; URINARY BLADDER NEOPLASMS;

EID: 84859463411     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10571.x     Document Type: Article

References (26)

1. Babjuk M, Oosterlinck W, Sylvester RJ, Kaasinen E, Bohle A, Palou J,. Guidelines on TaT1 (non-muscle invasive) Bladder Cancer. In: EAU guidelines ISBN: 978-90-70244-91-0; 2008.
2. Babjuk M,. Transurethral resection of non-muscle invasive bladder cancer. Eur Urol Suppl 2009; 8: 542-8
3. Brausi M, Collette L, Kurth K, et al,. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002; 41: 523-31
4. Mariappan P, Smith G, Lamb ADG, Grigor KM, Tolley DA,. Pattern of recurrence changes in noninvasive bladder tumours observed during 2 decades. J Urol 2007; 177: 867-75 (Pubitemid 46216357)
5. Herr HW, Machele SD,. A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 2005; 97: 1194-98
6. Grimm M-O, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vogeli AT,. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003; 170: 433-7 (Pubitemid 36870218)
7. Brauers A, Buettner R, Jakse G,. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early. J Urol 2001; 165: 808-10 (Pubitemid 32156283)
8. Mariappan P, Zachou A,. Grigor KM and members of the Edinburgh Uro-oncology group. Detrusor muscle in the first, apparently complete TURBT specimen is a surrogate marker of resection quality, predicts early recurrence and is dependent on operator experience. Eur Urol 2009; 57: 843-9 (online early)
9. Mariappan P, Smith G,. A surveillance schedule in G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years: based on a 25-year prospective database. J Urol 2005; 173: 1108-11 (Pubitemid 40380512)
10. Sylvester RJ, Oosterlinck W, van der Meijden AP,. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a metaanalysis of published results of randomized clinical trials. J Urol 2004; 171: 2186-90 (Pubitemid 38625431)
11. Sylvester RJ, van der Meijden AP, Lamm DL,. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 2002; 168: 1964-70
12. Herr HW,. The value of a second transurethral resection in evaluating patients with bladder tumours. J Urol 1999; 162: 74-6 (Pubitemid 29420883)
13. Maruniak N, Takezawa K, Murphy W,. Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol 2002; 167: 2404-7 (Pubitemid 34533134)
14. Dalbagni G, Herr HW, Reuter V,. Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology 2002; 60: 822-5
15. Dutta SC, Smith JAJ, Shappell SB, Coffey CS, Chang SS, Cookson MS,. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 2001; 166: 490-3 (Pubitemid 32652229)
16. Herr HW, Donat MS,. Quality control in transurethral resection of bladder tumours. BJU Int 2008; 102: 1242-6
17. Adiyat KT, Katkoori D, Soloway CT, et al,. ' Complete Transurethral Resection of Bladder Tumour': are the guidelines being followed. Urology 2010; 75: 365-8
18. Koloszy Z,. Histopathological 'self control' in TUR of bladder tumours. Br J Urol 1991; 67: 1761-4
19. Jesuraj MG, Harris M, Rogers A, Whiteway JE,. Completeness of the first resection of bladder tumour depending on the seniority of the surgeon. Eur Urol 2008; 7 (Suppl. 3): 269
20. Brausi M, Gavioli M, Peracchia G, et al,. Dedicated teaching programs can improve the quality of TUR of non-muscle invasive bladder tumour (NMIBT): experience of a single institution. Eur Urol 2008; 7 (Suppl. 3): 437
21. Nieder AM, Brausi M, Lamm D, et al,. Management of stage T1 tumours of the bladder: international consensus panel. Urology 2005; 66 (Suppl. 6A): 108-25 (Pubitemid 43049612)
22. Manoharan M, Soloway MS,. Optimal management of the T1G3 bladder cancer. Urol Clin North Am 2005; 32: 133-45 (Pubitemid 40613040)
23. Balbay DM, Ersin C, Unsal A, Bayrak O, Koc A, Akbulut Z,. The actual incidence of bladder perforation following transurethral bladder surgery. J Urol 2005; 174: 2260-3
24. Skolarikos A, Chrisofos M, Ferakis N, Papatsoris A, Dellis A, Deliveliotis C,. Does the management of bladder perforation during transurethral resection of superficial bladder tumours predispose to extravesical tumour recurrence? J Urol 2005; 173: 1908-11 (Pubitemid 40675208)
25. Oosterlinck W, Lobel B, Jakse G, Malmström P-U, Stöckle M, Sternberg C,. Guidelines on bladder cancer. Eur Urol 2002; 41: 105-12 (Pubitemid 35428874)
26. Anderson CH, Lee H, Rai BP, et al,. RRFFC following PDD-TURBT is better than even GQ-WLTURBT-a prospective controlled study. BJU Int 2010; 108 (Suppl. 1): 6